Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“If MAPS' wholly owned pharmaceutical arm, the MAPS Public Benefit Corporation (MAPS PBC), was publicly traded, it would probably have a market cap in the range of or exceeding these other companies.”
· From the Desk of Rick Doblin, Ph.D. – Bulletin Vol. 31, No. 2 · own post

Vol. 31 No. 2 column. Hypothetical valuation of MAPS PBC compared with publicly traded psychedelic companies with market caps above $1.35 billion.

Descriptive, retrospective, or a statement of preference; no future state asserted.